Cite
A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer
MLA
Mingjia Xiao, et al. “A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer.” Frontiers in Immunology, vol. 13, Feb. 2022. EBSCOhost, https://doi.org/10.3389/fimmu.2022.803962.
APA
Mingjia Xiao, Xiangjing Liang, Zhengming Yan, Jingyang Chen, Yaru Zhu, Yuan Xie, Yang Li, Xinming Li, Qingxiang Gao, Feiling Feng, Gongbo Fu, & Yi Gao. (2022). A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.803962
Chicago
Mingjia Xiao, Xiangjing Liang, Zhengming Yan, Jingyang Chen, Yaru Zhu, Yuan Xie, Yang Li, et al. 2022. “A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer.” Frontiers in Immunology 13 (February). doi:10.3389/fimmu.2022.803962.